← Leaderboards
Prasenjit Dey
University Of Tx Md Anderson Can Ctr
$3,083,364
Attributed
$3,083,364
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $676.9K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,083,364 · 3
By mechanism
R01$2,165,563 · 1
R00$746,999 · 1
K99$170,802 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Ronald Anthony Depinho$97,148,322
- Scott Kopetz$13,199,822
- Glen Traver Hart$5,258,043
Others in their field
Other Emerging Leaders on “Insight”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Beth Baseler · Leidos Biomedical Research, Inc.$91,415,673
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
Research focus
InsightPlayCellsTumorPancreatic Ductal AdenocarcinomaFutureMediatingMolecularMalignant NeoplasmsMalignant Neoplasm Of PancreasTherapy ResistantExperimental StudySurvival RateOncogenesTumor ProgressionMouse ModelPancreatic Ductal Adenocarcinoma CellInterleukin-13InfiltrationCancer CellInflammatoryLymphoid CellAntibodiesClinical Research
Grant awards (12)
Role of type 2 immune response in pancreatic cancer tumorigenesis$404,550
R01 · FY2025 · CA · contact PI
Role of type 2 immune response in pancreatic cancer tumorigenesis$71,398
R01 · FY2025 · CA · contact PI
Role of type 2 immune response in pancreatic cancer tumorigenesis$388,432
R01 · FY2024 · CA · contact PI
Role of type 2 immune response in pancreatic cancer tumorigenesis$58,959
R01 · FY2024 · CA · contact PI
Role of type 2 immune response in pancreatic cancer tumorigenesis$399,058
R01 · FY2023 · CA · contact PI
Role of type 2 immune response in pancreatic cancer tumorigenesis$415,258
R01 · FY2022 · CA · contact PI
Role of type 2 immune response in pancreatic cancer tumorigenesis$427,908
R01 · FY2021 · CA · contact PI
Targeting Malic Enzyme 3 as a Synthetic Lethality Target in Pancreatic Cancer$249,000
R00 · FY2021 · CA · contact PI
Targeting Malic Enzyme 3 as a Synthetic Lethality Target in Pancreatic Cancer$249,000
R00 · FY2020 · CA · contact PI
Targeting Malic Enzyme 3 as a Synthetic Lethality Target in Pancreatic Cancer$248,999
R00 · FY2019 · CA · contact PI
Targeting malic enzyme 3 as a synthetic lethality target in pancreatic cancer$85,401
K99 · FY2019 · CA · contact PI
Targeting malic enzyme 3 as a synthetic lethality target in pancreatic cancer$85,401
K99 · FY2018 · CA · contact PI